Press Releases

Media Contact: Michelle Kirkwood, Director, Strategic Communications and Media Relations,

The most recent press releases from the American Diabetes Association:

March 20, 2018
The American Diabetes Association Urges Americans to Learn Their Diabetes Risk and Take a Minute for their Loved Ones on March 27
On Tuesday, March 27, the American Diabetes Association (ADA) asks everyone to take the Type 2 Diabetes Risk Test for themselves or for a loved one to learn their risk for type 2 diabetes for Alert Day.

March 16, 2018
Nearly 200 Advocates, Researchers and Professional Football Players Will Assemble Thursday, March 22 for American Diabetes Association’s® Annual Call to Congress
On Thursday, March 22, the American Diabetes Association (ADA) will release its new “Economics of Diabetes in the U.S. in 2017” report, detailing the monetary impact of diabetes on our citizens individually and for the nation as a whole.

March 9, 2018
The American Diabetes Association®, the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators and the Endocrine Society Strongly Disagree with the American College of Physicians’ Guidance for Higher Blood Glucose Targets for People with Type 2 Diabetes
Together, the American Diabetes Association (ADA), the American Association for Clinical Endocrinologists (AACE), the American Association of Diabetes Educators (AADE) and the Endocrine Society strongly disagree with the American College of Physicians’ (ACP’s) proposed new guidance that suggests higher blood glucose targets for people with type 2 diabetes.

March 8, 2018
American Diabetes Association® Deeply Concerned About New Guidance from American College of Physicians Regarding Blood Glucose Targets for People with Type 2 Diabetes
The ADA is deeply concerned by the new guidance, “Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus: A Guidance Statement Update from the American College of Physicians,” published in the Annals of Internal Medicine on March 5, 2018.

March 6, 2018
American Diabetes Association Joins Class Action Lawsuit Against CoreCivic, the Nation's Second-Largest Private Prison Management Firm
In its continued commitment to improving the lives of all people living with and affected by diabetes, the American Diabetes Association (ADA) today announced that it is requesting to join a class action lawsuit, Civil Action No. 3:17-cv-00048, against CoreCivic, Inc., the second-largest private prison management company in the U.S., and the Tennessee Department of Correction.

February 21, 2018
American Diabetes Association Names John J. Agos as New Chief Strategic Development Officer
Accomplished healthcare executive John J. Agos has been named Chief Strategic Development Officer (CSDO) for the ADA.

February 9, 2018
American Diabetes Association Celebrates Renewal of Special Diabetes Program
The American Diabetes Association (ADA) stands today with millions of Americans, including more than 114 million living with or at risk for diabetes and more than half a million Diabetes Advocates across the country, to celebrate the inclusion of $600 million in funding for the Special Diabetes Program (SDP) in the federal budget agreement passed by Congress and signed by the president earlier today.

February 5, 2018
American Diabetes Association Awards $9.75 million to Six Leading Researchers for the 2018 Pathway to Stop Diabetes® Research Grants
The ADA cnnounced awarding $9.75 million to six recipients of the 2018 Pathway to Stop Diabetes (Pathway) research grants, providing $1.625 million to each scientist over a five- to seven-year grant term to spur breakthroughs in fundamental diabetes science, technology, diabetes care and potential cures.

January 24, 2018
More than 40 American Diabetes Association Current and Past Presidents Demand Congress Renew Special Diabetes Program Funding
In a letter to congressional leadership, more than 40 current and past presidents of the American Diabetes Association (ADA) came together to demand that Congress renew funding for the Special Diabetes Program (SDP).

January 12, 2018
American Diabetes Association Disappointed by Centers for Medicare and Medicaid Services Recent Decision to Allow States to Impose Medicaid Work Requirements
The American Diabetes Association (ADA) is deeply disappointed by the Centers for Medicare and Medicaid Services’ (CMS) decision to allow states to impose work requirements as a condition of Medicaid eligibility.

January 8, 2018
American Diabetes Association Thanks the 2017 Principal Officers and Welcomes 2018 Officers and New Members to National Board of Directors
The ADA thanks the four Principal Officers who helped the ADA raise awareness of diabetes and improve the lives of those living with and affected by diabetes throughout 2017, and welcomes the 2018 Principal Officers and Board of Directors.

December 20, 2017
17 Patient Advocacy Organizations: Congress Must Act to Stabilize Insurance Markets After Repealing Individual Mandate
As the Tax Cuts and Jobs Act awaits the president’s signature after passage by Congress today, a group of 17 non-partisan patient and consumer organizations issued the following statement.

December 8, 2017
American Diabetes Association Releases 2018 Standards of Medical Care in Diabetes, with Notable New Recommendations for People with Cardiovascular Disease and Diabetes
Notable new recommendations in the 2018 edition of the Standards of Care include advances in cardiovascular disease risk management including hypertension; an updated care algorithm that is patient-focused; the integration of new technology into diabetes management; and routine screening for type 2 diabetes in high-risk youth.

December 6, 2017
American Diabetes Association Supported by 25 Players During NFL’s My Cause My Cleats Campaign
During Week 13 of the 2017 NFL season, 25 NFL players participated in the league’s My Cause My Cleats campaign with custom-designed cleats to bring awareness to the diabetes epidemic ADA efforts to improve the lives of people living with diabetes and find potential cures.

December 2, 2017
Individual Mandate Repeal Will Deprive More Americans of Affordable Health Care, say 15 Patient and Consumer Groups
Today a group of 15 non-partisan patient and consumer organizations issued the following statement after the passage of the Senate Tax Cuts and Jobs Act.

November 30, 2017
12 Patient and Consumer Groups: CBO Confirms that Alexander-Murray Bill Is Not a Fix for Repealing the Individual Mandate
The ADA joined 11 other patient advocacy organizations to oppose the repeal of the Affordable Care Act's individual mandate in the Senate's proposed tax legislation.

November 21, 2017
American Diabetes Association® Issues Consensus Report to Standardize Definitions and Outcome Measures Beyond HbA1C for Type 1 Diabetes in Special Diabetes Care Section
A special section in Diabetes Care includes a Consensus Report and new CGM research highlighting the critical value of data from CGM devices. The issue explores how outcomes beyond HbA1C can lead to improved individualized diabetes care plans, patient-reported outcomes and quality of life.

November 3, 2017
American Diabetes Association Receives Five-Year, CDC Cooperative Agreement to Establish a Multi-state Network of Sites to Address Prediabetes
The Centers for Disease Control and Prevention (CDC) has awarded the American Diabetes Association a five-year, cooperative agreement to support the expansion of the National Diabetes Prevention Program (National DPP) to underserved areas in the U.S.

November 1, 2017
This November, It’s Up to Everyone to Put on Their Capes and Take a Stand Against Diabetes – This Is Diabetes
In recognition of November as American Diabetes Month, the American Diabetes Association® (Association) reminds us that there’s a hero inside everyone affected by diabetes.

October 25, 2017
American Diabetes Association Issues Scientific Statement on Improving Clinical Value and Use of Continuous Glucose Monitoring Systems
Acknowledging the potential benefit of CGM technology for people with diabetes and the need for standardized recommendations on how health care professionals, CGM manufacturers, regulatory authorities, policymakers and consumers can best ensure effective and appropriate use of CGM systems, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) convened a team of experts to produce a joint scientific statement, “Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations."

  • Last Reviewed: November 18, 2013
  • Last Edited: January 23, 2018